Safety of the Zoster Vaccine Recombinant Adjuvanted in Rheumatoid Arthritis and Other Systemic Rheumatic Disease Patients: A Single Center's Experience With 400 Patients

Objective Patients with rheumatoid arthritis (RA) and other systemic rheumatic diseases (SRDs) are at increased risk of developing herpes zoster (HZ). Zoster recombinant adjuvanted (ZRA) is a recombinant vaccine approved by the Food and Drug Administration in 2018. Concern has been raised that the Z...

Full description

Bibliographic Details
Main Authors: Emma Stevens, Michael E. Weinblatt, Elena Massarotti, Frances Griffin, Srinivas Emani, Sonali Desai
Format: Article
Language:English
Published: Wiley 2020-06-01
Series:ACR Open Rheumatology
Online Access:https://doi.org/10.1002/acr2.11150